Transcript
Page 1: Screening Process for a Global Private Equity Fund

SCREENING PROCESS

July 8, 2013

Page 2: Screening Process for a Global Private Equity Fund

Initial Screen

2

• SGD• SGX• Singapore Companies• 5m < EBITDA < 15m• EBITDA Margins > 15%• CAGR 4-FY > 10%• PX/EBITDA < 7 times

Page 3: Screening Process for a Global Private Equity Fund

Initial Screen

133

39

15

778

6

778SGD, SGX

5M < EBITDA < 15M

EBITDA Margin >15%

CAGR > 10%

Price/EBITDA < 7 Times

Page 4: Screening Process for a Global Private Equity Fund

Without EBITDA Margin

4

778

133

42

21

SGD, SGX

5M < EBITDA < 15M

CAGR > 10%

Price/EBITDA < 7 Times

Page 5: Screening Process for a Global Private Equity Fund

Without CAGR

5

778

133

39

18

SGD, SGX

5M < EBITDA < 15M

EBITDA Margin >15%

Price/EBITDA < 7 Times

Page 6: Screening Process for a Global Private Equity Fund

6

Without EBITDA Margin

Without CAGR

Original Screen WITH BOTH EBITDA Margin and CAGR

21

6

18

Page 7: Screening Process for a Global Private Equity Fund

Changes in EBITDA

7

2019181716151413121110986 7543

Nu

mb

er o

f F

irm

s

EBITDA (Millions)

+2 Firms

12

11

10

9

8

6

7

+3 Firms

Original

Page 8: Screening Process for a Global Private Equity Fund

Changes in EBITDA Margin

8

>16>15>14>13>12>11>10>8 >9>7>6

Nu

mb

er o

f F

irm

s

EBITDA Margin (%)

12

11

10

9

8

6

7

Original

Page 9: Screening Process for a Global Private Equity Fund

Changes in CAGR

9

>15>14>13>12>11>10>9>7 >8>6>5

Nu

mb

er o

f F

irm

s

4 Year CAGR (%)

Original

12

11

10

9

8

6

7

Page 10: Screening Process for a Global Private Equity Fund

Screening Comparison

10

• Original Screen– 5M < EBITDA < 15M– EBITDA Margin > 15%– CAGR 4-FY > 10%– Price/EBITDA < 7 times– Result: 6 Firms

Page 11: Screening Process for a Global Private Equity Fund

Screening Comparison

11

• No CAGR–5M < EBITDA < 15M–EBITDA Margin > 15%–Price/EBITDA < 7 times–Result: 18 Firms

• No CAGR, No Price/EBITDA–5M < EBITDA < 15M–EBITDA Margin > 15%–Result: 39 Firms

Page 12: Screening Process for a Global Private Equity Fund

Screening Comparison

12

• No EBITDA Margin– 5M < EBITDA < 15M– CAGR 4-FY > 10%– Price/EBITDA < 7 times– Result: 21 Firms

• No EBITDA Margin, No Price/EBITDA– 5M < EBITDA < 15M– CAGR 4-FY > 10%– Result: 42 Firms


Recommended